Emerging two-dimensional material nanozymes for theranostic nanomedicine.

Yanling You, Zhongmin Tang, Han Lin, Jianlin Shi
{"title":"Emerging two-dimensional material nanozymes for theranostic nanomedicine.","authors":"Yanling You,&nbsp;Zhongmin Tang,&nbsp;Han Lin,&nbsp;Jianlin Shi","doi":"10.52601/bpr.2021.210011","DOIUrl":null,"url":null,"abstract":"<p><p>Nanomaterials-based artificial enzymes (nanozymes) with valuable enzyme-like catalytic properties have been booming during the past few years. Promoted by the advances in biological medicine and nanotechnology, nanozymes possess the potential to serve as an emerging agent for biosensing, immunoassays, detection and diagnosis, catalytic therapeutics, and other applications in the biomedicine field. Two-dimensional (2D) nanomaterials are of considerable interest in biomedical applications due to their ultrathin layered structure and unique physiochemical properties. Inspired by the diversified catalytic performance of 2D nanomaterials, scientists extensively have developed 2D materials as bioactive nanozymes for theranostic nanomedicine. Here, recent advances in enzyme-like 2D nanomaterials design and construction are comprehensively presented. Additionally, we exhibit that, with the synergistic effect of catalytic activities and desirable physicochemical performances, 2D nanozymes can serve as versatile platforms with extensive applications from target detection to <i>in vivo</i> theranostic. It is believed that such promising alternatives towards natural enzymes will be of vital significance in the field of nanotechnology and biomedicine.</p>","PeriodicalId":59621,"journal":{"name":"生物物理学报:英文版","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244796/pdf/","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"生物物理学报:英文版","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52601/bpr.2021.210011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Nanomaterials-based artificial enzymes (nanozymes) with valuable enzyme-like catalytic properties have been booming during the past few years. Promoted by the advances in biological medicine and nanotechnology, nanozymes possess the potential to serve as an emerging agent for biosensing, immunoassays, detection and diagnosis, catalytic therapeutics, and other applications in the biomedicine field. Two-dimensional (2D) nanomaterials are of considerable interest in biomedical applications due to their ultrathin layered structure and unique physiochemical properties. Inspired by the diversified catalytic performance of 2D nanomaterials, scientists extensively have developed 2D materials as bioactive nanozymes for theranostic nanomedicine. Here, recent advances in enzyme-like 2D nanomaterials design and construction are comprehensively presented. Additionally, we exhibit that, with the synergistic effect of catalytic activities and desirable physicochemical performances, 2D nanozymes can serve as versatile platforms with extensive applications from target detection to in vivo theranostic. It is believed that such promising alternatives towards natural enzymes will be of vital significance in the field of nanotechnology and biomedicine.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于治疗性纳米医学的新兴二维材料纳米酶。
基于纳米材料的人工酶(nanozymes)具有宝贵的酶样催化性能,在过去的几年里得到了蓬勃发展。在生物医学和纳米技术进步的推动下,纳米酶在生物传感、免疫分析、检测和诊断、催化治疗和其他生物医学领域的应用中具有潜力。二维(2D)纳米材料由于其超薄的层状结构和独特的物理化学性质而在生物医学应用中引起了相当大的兴趣。受到二维纳米材料多样化催化性能的启发,科学家们广泛开发了二维材料作为治疗纳米药物的生物活性纳米酶。本文全面介绍了类酶二维纳米材料的设计和构建的最新进展。此外,我们还发现,由于催化活性和理想的物理化学性能的协同作用,2D纳米酶可以作为多功能平台,从目标检测到体内治疗都有广泛的应用。相信这些有前途的天然酶替代品将在纳米技术和生物医学领域具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.30
自引率
0.00%
发文量
117
期刊最新文献
Multi-phase separation in mitochondrial nucleoids and eukaryotic nuclei. Synergistic glycolysis disturbance for cancer therapy by a MOF-based nanospoiler. M6A RNA methylation modification and tumor immune microenvironment in lung adenocarcinoma. Antioxidant activity of the thioredoxin system. The risk model construction of the genes regulated by H3K36me3 and H3K79me2 in breast cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1